Related Experiment Video

Updated: Jun 5, 2026

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

Implication of oncogenic signaling pathways as a treatment strategy for neurodegenerative disorders - contemporary

Adrian Sieradzki1, Bharat B Yendluri, Hector H Palacios

  • 1Department of Neurology, Faculty of Health Science, Wroclaw Medical University, 5 K. Bartla Str., 51-618 Wroclaw, Poland.

CNS & Neurological Disorders Drug Targets
|January 13, 2011
PubMed

Insights

Aberrant cell cycle re-expression in neurons is linked to Alzheimer's and Parkinson's diseases. Research explores oncogenic factors for potential treatments for these neurodegenerative conditions.

Area of Science:

  • Neuroscience
  • Oncology
  • Pathology

Background:

  • Chronic neurodegenerative diseases like Alzheimer's and Parkinson's share a commonality in neuronal cell vulnerability.
  • Aberrant re-expression of cell cycle control elements in proximal neurons is increasingly associated with this vulnerability.
  • This phenomenon is linked to the activation of oncogenic signal transduction pathways.

Purpose of the Study:

  • To review and outline research areas focusing on oncogenic factors and related medicines.
  • To explore the potential therapeutic applications of targeting oncogenic pathways in neurodegenerative diseases.
  • To provide insights into future treatment strategies for Alzheimer's and Parkinson's diseases.

Main Methods:

  • Literature review of recent evidence on cell cycle re-expression in neurodegeneration.
  • Analysis of studies investigating oncogenic pathway activation in neuronal vulnerability.
  • Synthesis of research findings on potential oncogenic-based therapeutic interventions.

Main Results:

  • Evidence links proximal neuronal cell cycle re-expression to vulnerability in Alzheimer's and Parkinson's.
  • Activation of oncogenic transduction pathways is a significant factor in this neurodegenerative process.
  • Several research avenues are emerging for targeting oncogenic factors therapeutically.

Conclusions:

  • Targeting oncogenic pathways presents a promising, albeit nascent, therapeutic strategy for chronic neurodegenerative diseases.
  • Further research into oncogenic factors and medicines is warranted for Alzheimer's and Parkinson's disease treatment.
  • Understanding the interplay between cell cycle control and oncogenesis is crucial for developing novel neuroprotective treatments.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...